Pulmonary Veno-Occlusive Disease: Clinical Trials

2 trials for Pulmonary Veno-Occlusive Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Pulmonary Veno-Occlusive Disease: new trials by email Literature Review of Pulmonary Veno-Occlusive Disease trials Research Report on Pulmonary Veno-Occlusive Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis
Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) - Pulmonary Veno Occlusive Disease
Phase 1 / Phase 2CompletedBoston Children's Hospital502008-10-012019-06-19
Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients
Glutamine - Pulmonary Veno-Occlusive Disease, Hepatic Veno-Occlusive Disease
Not applicableUnknownHospital Authority, Hong Kong402004-07-012010-07-07

Narrower conditions

Hepatic Veno-Occlusive Disease (1)  ·  Mucositis (1)  ·  Stenosis, Pulmonary Vein (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Vascular Diseases (2)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Liver Diseases (1)  ·  Mouth Diseases (1)  ·  Stomatognathic Diseases (1)

Interventions

Bevacizumab (1)  ·  Glutamine (1)  ·  Imatinib Mesylate (1)

Sponsors

Boston Children's Hospital (1)  ·  Hospital Authority, Hong Kong (1)

Countries

China (1)  ·  United States (1)

Top investigators

Albert Lie, Dr (1)  ·  Kathy J Jenkins, MD, MPH (1)